Profusa, Inc. (Nasdaq: PFSA) is a South San Francisco digital-health and medical-device company that builds tissue-integrated biosensors — injectable, biologically compatible hydrogel microsensors smaller than a grain of rice — for continuous, real-time monitoring of body chemistry. Its Lumee Oxygen Platform reports tissue oxygen for peripheral artery disease, chronic wounds and reconstructive surgery, and a long-duration Lumee glucose sensor is in development. A companion Data Platform turns raw sensor readings into clinical intelligence for clinicians, with EMR integration described as planned rather than shipped. Profusa has received more than USD 23M in NIH and DARPA funding and became publicly traded in July 2025 through a business combination with NorthView Acquisition Corporation. As of this profiling pass the company publishes no developer program, no public API documentation and no machine-readable API contract.
Profusa is profiled on the APIs.io network. Tagged areas include Company, Health, Medical Devices, Biosensors, and Digital Health.
Profusa’s developer surface includes support, engineering blog, and 8 more developer resources.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/profusa: open an issue to ask a question, or submit a pull request to add artifacts.
Submit an artifact on GitHub — free →Manage your own listing — the Influence plan, $499/mo →
aid: profusa
name: Profusa
description: 'Profusa, Inc. (Nasdaq: PFSA) is a South San Francisco digital-health and medical-device company that builds
tissue-integrated biosensors — injectable, biologically compatible hydrogel microsensors smaller than a grain of rice —
for continuous, real-time monitoring of body chemistry. Its Lumee Oxygen Platform reports tissue oxygen for peripheral artery
disease, chronic wounds and reconstructive surgery, and a long-duration Lumee glucose sensor is in development. A companion
Data Platform turns raw sensor readings into clinical intelligence for clinicians, with EMR integration described as planned
rather than shipped. Profusa has received more than USD 23M in NIH and DARPA funding and became publicly traded in July
2025 through a business combination with NorthView Acquisition Corporation. As of this profiling pass the company publishes
no developer program, no public API documentation and no machine-readable API contract.'
url: https://raw.githubusercontent.com/api-evangelist/profusa/refs/heads/main/apis.yml
x-api-posture: no-product-api
x-api-posture-basis: observed
x-api-posture-note: As of this profiling pass the company publishes no developer program, no public API documentation and
no machine-readable API contract.
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- security
generated: '2026-09-02'
method: derived
image: https://profusa.com/wp-content/uploads/2015/12/cropped-profusa-logo-1-270x270.png
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Health
- Medical Devices
- Biosensors
- Digital Health
- Continuous Monitoring
- Diagnostics
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/profusa-domain-security.yml
- type: Website
url: https://profusa.com/
- type: About
url: https://profusa.com/about-profusa/
- type: Support
url: https://profusa.com/contact-profusa/
- type: Blog
url: https://investors.profusa.com/press-releases
- type: BlogRSS
url: https://profusa.com/feed/
- type: Careers
url: https://profusa.com/careers-profusa/
- type: InvestorRelations
url: https://investors.profusa.com/
- type: LinkedIn
url: https://www.linkedin.com/company/profusa
- type: LLMsTxt
url: llms/profusa-llms.txt
x-enrichment:
date: '2026-08-26'
status: minimal
artifacts_added: 3
pass: local-v1
x-coverage:
state: none
reason: no-developer-program
detail: Profusa ships a clinical Data Platform and a phone app for its Lumee biosensors but publishes nothing for developers
— profusa.com is a WordPress marketing site whose only machine-readable surface is the generic WordPress core REST discovery
document at /wp-json/, and every developer path (/developers, /api, /docs, /openapi.json, /llms.txt, /.well-known/*) returns
404, while investors.profusa.com answers 200 with an SPA shell for every path including /.well-known/agent-card.json.
evidence:
- url: https://profusa.com/developers
status: 404
- url: https://profusa.com/openapi.json
status: 404
- url: https://profusa.com/llms.txt
status: 404
- url: https://profusa.com/.well-known/agent-card.json
status: 404
- url: https://profusa.com/wp-json/
status: 200
- url: https://investors.profusa.com/.well-known/agent-card.json
status: 200
checked: '2026-08-26'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.